Patent · US Active

Drug-induced activation of the Reelin signaling system

US11629127B2 · kind B2 · utility

3Cited by

9References

15Claims

0Family size

Assignee

University of South Florida · US

Inventors

Edwin John Weeber · Apollo Beach, US
Qingyou Li · Tampa, US
Melinda Peters · Riverview, US
Hana Marie Soueidan · Wesley Chapel, US

Key dates

Filing date	Apr 18, 2022
Grant date	Apr 18, 2023
Priority date	—
Expiry date	Apr 18, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D235/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compounds for activating the Reelin signaling system for the treatment of neurological disorders Further provided are compounds and methods for activating a lipoprotein receptor, such as ApoER2 or VLDLR.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.